[144] BorgWarner Inc. SEC Filing

Rhea-AI Filing Summary

BorgWarner Inc. insider filing shows a proposal to sell 3,500 common shares through Charles Schwab & Co., Inc. on the NYSE with an aggregate market value of $154,632 and an approximate sale date of 09/11/2025. The securities were acquired in 2025 as equity compensation: 2,543 shares from a performance stock lapse on 02/05/2025 and 957 shares from a restricted stock lapse on 02/28/2025. The filer previously sold 13,190 shares over August–September 2025 for total gross proceeds of $534,395. The notice includes the signature representation that no undisclosed material adverse information is known.

Positive

• Acquisitions were equity compensation, indicating sales derive from vested awards rather than market purchases
• Broker and exchange identified (Charles Schwab & Co.; NYSE), supporting orderly execution

Negative

• None.

Insights

Financial Analyst

TL;DR: This Form 144 reports routine insider disposals of recently vested equity, with prior August sales totaling 13,190 shares for $534,395.

The filing documents a proposed sale of 3,500 shares valued at $154,632 to be executed through Charles Schwab on the NYSE. All reported acquisitions were equity compensation in early 2025, indicating sales relate to recently vested awards rather than open-market purchases. The recent history of multiple sales in August and early September 2025 suggests ongoing disposition of vested holdings. There is no information in this notice about any material nonpublic information or changes to company operations.

Corporate Governance Expert

TL;DR: Filing appears procedurally compliant under Rule 144, documenting vesting and planned sales with required signer representation.

The Form 144 identifies the seller, the broker, acquisition dates and the nature of acquisition (performance lapse and restricted stock lapse), meeting disclosure expectations for insider sales. The signature statement affirms absence of undisclosed material adverse information. The filing does not disclose any executive departures, trading plan adoption dates, or additional governance actions that would materially change stakeholder oversight.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	3500	154632.00	216392876	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/05/2025	Performance Stock Lapse	BORGWARNER INC			2543	02/05/2025	Equity Compensation
Common	02/28/2025	Restricted Stock Lapse	BORGWARNER INC			957	02/28/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Isabelle McKenzie 3850 HAMLIN RD. AUBURN HILLS MI 48326	BORGWARNER INC	08/04/2025	5000	188550.00
Isabelle McKenzie 3850 HAMLIN RD. AUBURN HILLS MI 48326	BORGWARNER INC	08/12/2025	2500	100025.00
Isabelle McKenzie 3850 HAMLIN RD AUBURN HILLS MI 48326	BORGWARNER INC	08/28/2025	2690	115470.00
Isabelle McKenzie 3850 HAMLIN RD AUBURN HILLS MI 48326	BORGWARNER INC	09/04/2025	3000	130350.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does BorgWarner (BWA) Form 144 filed here report?

The filing reports a proposed sale of 3,500 common shares valued at $154,632, to be sold on or about 09/11/2025 on the NYSE through Charles Schwab & Co.

Who is the seller named in the Form 144?

The prior sales list Isabelle McKenzie at the address shown as the seller for transactions in August–September 2025; the current notice does not restate the account holder name in the securities-to-be-sold table.

How were the shares acquired that are being sold?

The shares were acquired as equity compensation: 2,543 shares from a performance stock lapse on 02/05/2025 and 957 shares from a restricted stock lapse on 02/28/2025.

What prior sales are disclosed in the past three months?

The filer sold 13,190 shares on 08/04/2025, 08/12/2025, 08/28/2025, and 09/04/2025 for combined gross proceeds of $534,395.

Does the filing indicate undisclosed material information about BorgWarner?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.